A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients

Stem Cells

Volumn 23, Issue 3, 2005, Pages 324-334

  Bornstein, Rafael ^a   Flores, Ana I ^a   Montalbán, M Angeles ^a   Del Rey, Manuel J ^a   De La Serna, Javier ^a   Gilsanz, Florinda ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Antigens; CD34; Cord blood banks; Cord blood stem cell transplantation Hematopoietic stem cells; Placental circulation

Indexed keywords

ARTICLE; BACTERIUM CONTAMINATION; CELL SURVIVAL; CELL TRANSPLANTATION; HUMAN; HUMAN CELL; NEWBORN; PLACENTA PERFUSION; STEM CELL; UMBILICAL CORD BLOOD TRANSPLANTATION; VEIN PUNCTURE;

ADULT; ANTIGENS, CD; BLOOD CELL COUNT; BLOOD SPECIMEN COLLECTION; CORD BLOOD STEM CELL TRANSPLANTATION; DNA; ERYTHROID PROGENITOR CELLS; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; GRANULOCYTE PRECURSOR CELLS; HEMATOPOIETIC STEM CELLS; HLA-DR ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; PERFUSION; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; UMBILICAL CORD;

BACTERIA (MICROORGANISMS);

EID: 15544364942     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0047     Document Type: Article

References (63)

1. Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802.
2. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
3. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-381.
4. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
5. Thomson BG, Robertson KA, Gowan D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000;96:2703-2711.
6. Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-2971.
7. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999;93:3662-3671.
8. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-1822.
9. Barker JN, Davies SM, DeFor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-2961.
10. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-1618.
11. Michel G, Rocha V, Chevret S et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003;102:4290-4297.
12. Rubinstein P, Carrier C, Carpenter C et al. Graft selection in unrelated placental/umbilical cord blood (PCB) transplantation: influence and weight of HLA match and cell dose on engraftment and survival. Blood 2000;96:588a.
13. Stevens CE, Scaradavou A, Rubinstein P. Does patient age affect outcome in cord blood transplants? A retrospective analysis of 1101 transplants from the New York Blood Center's National Cord Blood Program. Blood 2002;100:641a.
14. Sanz FG, Saavedra S, Flanelles D et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001;98:2332-2338.
15. Ooi J, Iseki T, Takahashi S et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003;101:4711-4713.
16. Ooi J, Iseki T, Takahashi S et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-491.
17. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000;28:1197-1205.
18. Rocha V, Chastang C, Laporte JP et al. Unrelated umbilical cord blood transplants in adults with hematologic malignancies. Blood 1998;92:144a.
19. Gluckman E. Hematopoietic stem-cell transplants using umbi lical-cord blood. N Engl J Med 2001;344:1860-1861.
20. Laporte JP, Lesage S, Portnoï MF et al. Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience. Bone Marrow Transplant 1998;22(Suppl 1):S76-77.
21. Rocha V, Chastang C, Souillet G et al. Related cord blood transplant: the Eurocord experience from 78 transplants. Bone Marrow Transplant 1998;21(Suppl 3):S59-62.
22. Long GD, Laughlin M, Madan B et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003;12:772-780.
23. Barker J, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer 2003;3:526-532.
24. Kögler G, Sarnowski A, Wernet P. Volume reduction of cord blood by Hetastarch for long-term stem cell banking. Bone Marrow Transplant 1998;22(Suppl 1):S14-15.
25. Querol S, Gabarró M, Amat L et al. The placental blood program of the Barcelona Cord Blood Bank. Bone Marrow Transplant 1998;22(Suppl 1):S3-5.
26. Jones J, Stevens CE, Rubinstein Pet al. Obstetric predictors of placental/umbilical cord blood volume for transplantation. Am J Obstet Gynecol 2003;188:503-509.
27. Kögler G, Somville T, Göbel U et al. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany. Klin Pädiatr 1999;211:224-232.
28. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-10122.
29. Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996;5:213-226.
30. Prat I, Hernândez C, Muñoz M et al. Organization of an umbilical cord blood transplant program. Haematologica 1998;83:667-669.
31. Donaldson C, Buchanan R, Webster J et al. Development of a district Cord Blood Bank: a model for cord blood banking in the National Health Service. Bone Marrow Transplant 2000;25:899-905.
32. Thierry D, Traineau R, Adam M et al. Hematopoietic stem cell potential from umbilical cord blood. Nouv Rev Fr Hematol 1990;32:439-440.
33. Davey S, Armitage S, Rocha V et al. The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol 2004;125:358-365.
34. Reboredo NM, Díaz A, Castro A et al. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant 2000;26:1263-1270.
35. Ballen KK, Wilson M, Wuu J et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 2001;27:7-14.
36. Rubinstein P, Taylor PE, Scaradavou A et al. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells 1994;20:587-596.
37. Dal Cortivo L, Marolleau JP, Gluckman E et al. The Paris Cord Blood Bank. Bone Marrow Transplant 1998;22(Suppl 1):S11.
38. Socie G, Gluckman E, Carosella E et al. Search for maternal cells in human umbilical cord blood by poly merase chain reaction amplification of two minisatellite sequences. Blood 1994;83:340-344.
39. Briz M, Regidor C, Monteagudo D et al. Detection of maternal DNA in umbilical cord blood by polymerase chain reaction amplification of minisatellite sequences. Bone Marrow, Transplant 1998;21:1097-1099.
40. Kurtzberg J, Graham M, Casey J et al. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994;20:275-283.
41. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
42. Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997;15:1767-1777.
43. Weisdorf DJ. Bone marrow transplantation for acute lymphocytic leukemia (ALL). Leukemia 1997;11(Suppl 4): S20-22.
44. Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997;157:153-166.
45. Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000;25:797-799.
46. Shpall EJ, Quinones R, Guiller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-376.
47. Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex-vivo expanded UCB cells: results of a phase I trial using the Aastrom Replicell system. Blood 2003;101:5061-5067.
48. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344:1870-1871.
49. + cells from an HLA-haploidentical donor. Exp Hematol 2003;31:535-544.
50. Rizzieri DA, Long GD, Vredenburgh JJ et al. Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 2001;98:3486-3488.
51. Barker JN, Weisdorf DJ, DeFor TE et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003;102:1915-1919.
52. Turner CW, Luzins J, Hutcheson C. A modified harvest technique for cord blood hematopoietic stem cells. Bone Marrow Transplant 1992;10:89-91.
53. Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-2722.
54. + cells isolated from cord blood are highly enriched in long-term culture initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. STEM CELLS 1998;16:387-396.
55. + human cord blood cells. J Hematother Stem Cell Res 2000;9:827-840.
56. + hematopoietic stem cells. Ann N Y Acad Sci 2003;996:141-151.
57. Scaradavou A, Carrier C, Mollen N et al. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 1996;88:1494-1500.
58. Elchalal U, Fasouliotis SJ, Shtockheim D et al. Postpartum umbilical cord blood collection for transplantation: a comparison of three methods. Am J Obstet Gynecol 2000;182:227-232.
59. Screnci M, De Felice L, Carmini D et al. Does the type of delivery influence umbilical cord blood recovery? Bone Marrow Transplant 1995;16:631-632.
60. Surbek DV, Schönfeld B, Tichelli A et al. Optimizing cord blood mononuclear cell yield: a randomized comparison of collection before vs. after placenta delivery. Bone Marrow Transplant 1998;22:311-312.
61. Surbek DV, Visca E, Steinmann C et al. Umbilical cord blood collection before placental delivery during cesarean delivery increases cord blood volume and nucleated cell number available for transplantation. Am J Obstet Gynecol 2000;183:218-221.
62. Solves P, Mirabel V, Larrea L et al. Comparison between two cord blood collection strategies. Acta Obstet Gy necol Scand 2003;82:439-442.
63. Kurtzberg J, Issitt L, Caravan H et al. Cord blood collections ex utero are no different to cord blood collections in utero when performed by trained collection staff. Cytotherapy 2003;5:437a.